Phase 1 Pancreatic Neoplasms Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Ovarian NeoplasmsStomach NeoplasmsLung Neoplasms+5 more
National Cancer Institute (NCI)100 enrolled1 locationNCT06885697
Recruiting
Phase 1Phase 2
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer
Pancreatic CancerAdvanced CancerPancreatic Ductal Adenocarcinoma+1 more
Changhai Hospital30 enrolled1 locationNCT04146298
Recruiting
Phase 1Phase 2
HTL0039732 in Participants With Advanced Solid Tumours
SarcomaUrinary Bladder NeoplasmsUterine Cervical Neoplasms+11 more
Cancer Research UK150 enrolled5 locationsNCT05944237
Recruiting
Phase 1Phase 2
Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer
Pancreatic CancerPancreas CancerPancreatic Neoplasms+1 more
Chinese PLA General Hospital90 enrolled1 locationNCT05218889
Recruiting
Phase 1
PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
Stomach NeoplasmsPancreatic NeoplasmsEpithelial Ovarian Cancer+1 more
Karolinska University Hospital410 enrolled1 locationNCT05172310